AT
Actinogen Medical Limited
ATGGF · OTC
$0.04 +0.00% (+$0.00)
1M -12.50%
Market Cap $180.2M
P/E Ratio -
Div. Yield -
ROE 85.31%
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/B 8.44x
PEG N/A
P/E N/A
Growth
100 /100
Growing Book val. growth 16.77%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 52.03%
ROIC 58.92%
Asset turnover 0.00x
Debt
69 /100
Low Int. coverage -60.34x
Debt/Equity 0.22x
Current ratio 3.45x
Stability
56 /100
Moderate EPS volatility 11.80%
Beta 0.89x
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na ATGGF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Steven G. Gourlay
Employees
6
Headquarters
Sydney
Nadcházející události
24 ÚNO
Earnings
Upcoming earnings report